Shopping Cart
Remove All
Your shopping cart is currently empty
NLRP3-IN-42 (compound H28) is a potent inhibitor of NLRP3 with a KD value of 1.15 µM. It effectively reduces the protein expression of cleaved-caspase-1 (p20) induced by LPS and selectively inhibits the release of IL-1β.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | NLRP3-IN-42 (compound H28) is a potent inhibitor of NLRP3 with a KD value of 1.15 µM. It effectively reduces the protein expression of cleaved-caspase-1 (p20) induced by LPS and selectively inhibits the release of IL-1β. |
| Targets&IC50 | NLRP3:1.15 μM (kd) |
| In vitro | NLRP3-IN-42 (compound H28) effectively reduces the expression of cleaved-caspase-1 (p20) induced by LPS in a dose-dependent manner (0-30 µM). Additionally, NLRP3-IN-42 stably binds to the ADP active site of the NACHT domain of NLRP3. |
| In vivo | NLRP3-IN-42 (10 mg/kg; i.p.) selectively inhibits the release of IL-1β by suppressing the NLRP3 inflammasome, without significantly affecting the inflammatory factor TNF-α. |
| Formula | C29H27F3N2O3S2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.